Findings on compounds blocking SARS-COV-2 viral replication may offer a starting point for further development of treatments to address the ongoing, devastating novel coronavirus pandemic.

The College of Medicine – Phoenix is helping evaluate the quality of the research being released rapidly about the virus that causes COVID-19.

After finishing his degree at the University of Arizona as a doctor in pharmacy, Jeffrey Asman, 56, said the decision to go back to school in his “second half of life” was an easy one. “I was 48 or 49 wondering if my old college credits were any good. It is cliché to say but really true that it is never too late.”

Contact tracing is an indispensable part of breaking the chain of a pathogen's transmission and getting society back on track, according to most health officials including those at the Centers for Disease Control and Prevention. This process can seem intrusive, but public health agencies have honed it over decades. “We get people to tell us who their public contacts are when they have syphilis,” said Kristen Pogreba-Brown, an assistant professor of epidemiology at the University of Arizona Mel and Enid Zuckerman College of Public Health. “We know how to do this.”

Dr. Paul Gordon embarks on a multi-state bicycle “listening tour” to hear what people in rural areas think about the U.S. health care system amid the COVID-19 pandemic.

University of Arizona president, Dr. Robert Robbins announced in April his plans to resume in-person classes Aug. 24, bringing back 45,000 students and 15,000 faculty and staff for fall 2020.

Health Sciences researchers spearhead global effort to capture a snapshot of real-time critical care of pediatric COVID-19 patients.

Both the University of Arizona’s Dr. Noshene Ranjbar and Tufts University’s Dr. Andrea Gordon are recognized for their work in promoting Integrative Medicine in Residency Programs.